Almac has successfully completed an inspection of its Clinical Services operations in Craigavon by the UK MHRA. The routine inspection, which occurred September 17 - 20, concluded that the site continues to be compliant with EU GMP, with no critical or major failures observed.
 
Paul O’Connor, vice president of quality, said,“Once again we are extremely pleased with the outcome of our inspection. Quality is at the forefront of all our operations and all our employees continuously strive to ensure we have all the necessary processes in place to support our reputation in delivering global regulatory compliance and quality management excellence. This latest inspection is even more significant as it comes at an exciting time as we prepare to implement our new multi-million pound ERP system. This was reviewed intensively and resulted in no findings, testimony to our confidence that this exciting new development will further enhance our position as the premium supplier of global clinical supply chain solutions to the pharmaceutical and biotech industries.”
 
Almac has three MHRA approved clinical services facilities, including an additional FDA assessed U.S. facilities in Souderton, PA and Durham, NC.